Jan T. Kielstein

Serum uric acid and the risk of cardiovascular and renal disease

Claudio Borghi, Thomas Bardin, Jesse Dawson et al. · Journal of Hypertension · 2015 · 463 citations

Medicine, Nephrology, Pharmacology +15

Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

Gary R. Matzke, George R. Aronoff, Arthur J. Atkinson et al. · Kidney International · 2011 · 455 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Cardiovascular Effects of Systemic Nitric Oxide Synthase Inhibition With Asymmetrical Dimethylarginine in Humans

Jan T. Kielstein, Burcu Impraim, S. Simmel et al. · Circulation · 2003 · 404 citations · Full text

Medicine, Cardiology, Pharmacology +12

Marked Increase of Asymmetric Dimethylarginine in Patients with Incipient Primary Chronic Renal Disease

Jan T. Kielstein, Rainer H. BoCombining Diaeresisger, Stefanie M. Bode‐Böger et al. · Journal of the American Society of Nephrology · 2002 · 372 citations · Full text

Medicine, Nephrology, Renal Pathology +12

Asymmetric Dimethylarginine Plasma Concentrations Differ in Patients with End-Stage Renal Disease

Jan T. Kielstein, Rainer H. Böger, STEFANINE M. BODE-BÖGER et al. · Journal of the American Society of Nephrology · 1999 · 360 citations

Medicine, Nephrology, Pharmacology +13